Older studies have pointed to beta-endorphin as a potential biomarker for a positive treatment response in depression, but our findings indicate significant variability and uncertainty in measured values, suggesting the need for further investigation into its diagnostic utility [26,27]. Here, POMC is linked to depressive disorder.